Egypt Healthcare Authority Welcomes Janssen Pharmaceuticals, the Pharmaceutical Arm of Johnson & Johnson, at Its Facilities in Luxor
Chairman of Egypt Healthcare Authority: The Authority is Committed to Strengthening and Developing Collaborative Relations with the Private Sector. The Private Sector is a Key Partner in the Success of Healthcare System Development
Chairman of Egypt Healthcare Authority: Collaboration with Janssen is Vital in Meeting Citizens' Needs, Enhancing Quality of Life, and Achieving a Sustainable Health Environment
Executive Director of Janssen Pharmaceuticals for Egypt, North Africa, and Jordan: The Company Appreciates the Authority's Efforts in Improving Beneficiary Satisfaction and Looks Forward to Further Cooperation in the Coming Period
The Luxor branch of the Egypt Healthcare Authority welcomed a delegation from Janssen, the pharmaceutical arm of Johnson & Johnson, led by Mr. Sevan Kaloustian, Executive Director of Janssen Pharmaceuticals for Egypt, North Africa, and Jordan. The delegation was received by Dr. Ahmed El-Borai, Head of the Upper Egypt Region and Supervisor of the Luxor branch of the Egypt Healthcare Authority.
During the meeting, the discussion focused on ways to enhance cooperation between the Egypt Healthcare Authority and Janssen, particularly in training service providers on the latest global updates and treatment protocols for several diseases, including blood disorders, immune diseases, and supporting digital transformation to improve the working environment and provide data for decision-making. This collaboration aims to improve performance indicators and the quality of healthcare services provided in Upper Egypt.
Dr. Ahmed El-Borai also presented the performance indicators of the Luxor branch over the past three years, highlighting the role of the Authority in promoting the culture of health quality and improving medical services for beneficiaries, ensuring an improved patient experience within the facility. The delegation was given a tour of the Egypt Healthcare Authority's facilities in Luxor, where they observed the quality of healthcare services provided and received feedback from patients, including foreign tourists who praised the services they received.
Dr. Sevan Kaloustian praised the noticeable leap in the quality of medical services at the Egypt Healthcare Authority's facilities, noting the Authority's role in providing healthcare services according to the highest global quality standards, which aim to achieve sustainability. He expressed the company's appreciation for the Authority's efforts in improving beneficiary satisfaction and affirmed the company's eagerness for more cooperation with the Egypt Healthcare Authority in the future.
Dr. Ahmed El-Sebki, Chairman of the Egypt Healthcare Authority and General Supervisor of the Universal Health Insurance Project, emphasized the Authority’s commitment to enhancing and developing collaborative relationships with the private sector, which is a crucial partner in the success and sustainability of the healthcare system. He highlighted the government's support in creating a conducive environment for cooperation between the public and private sectors and health investment, which drives collaborative efforts towards achieving sustainable development, particularly in line with Egypt's Vision 2030.
Dr. El-Sebki expressed his appreciation for the collaboration with Janssen and his optimism about the future of healthcare in Egypt. He emphasized that the partnership with the private sector helps meet citizens' needs and improves quality of life while ensuring a sustainable health environment. He noted that the cooperation with Janssen includes various areas, especially raising health awareness and educating citizens about blood disorders, immune diseases, and rare diseases, contributing to improving the quality of life.
The Janssen delegation included Dr. Rania Ashraf, Head of Government Affairs at the company, Dr. Heba Hussein, Medical Director, Mr. Ahmed Abdel Fattah, Financial Director, Dr. Ragda Elbandary, Marketing and Sales Director, and Dr. Hatem Dawood, Market Support Director. From the Luxor branch of the Egypt Healthcare Authority, the meeting was attended by Dr. Ahmed Hamad, Deputy Director of the Luxor branch, Dr. Mohamed Abdel Hadi, Secondary Care Director, Mr. Mohamed Khalil, Digital Transformation Director, and other leadership team members.
